Abstract

Increasing evidence indicates that long non-coding RNAs (lncRNAs) play vital roles in the tumorigenesis and progression of cancers. However, the functions and regulatory mechanisms of lncRNAs in nasopharyngeal carcinoma (NPC) are still largely unknown. Our previous lncRNA expression profiles identified that LINC01503 was overexpressed in NPC. Here, we verified that LINC01503 was highly expressed in NPC and correlated with poor prognosis. LINC01503 promoted NPC cell proliferation, migration, and invasion in vitro, and facilitated tumor growth and metastasis in vivo. Mechanistically, LINC01503 recruited splicing factor proline-and glutamine-rich (SFPQ) to activate Fos like 1 (FOSL1) transcription, and ectopic expression of FOSL1 reversed the suppressive effect of LINC01503 knockdown on NPC progression. Moreover, androgen receptor (AR)-mediated transcription activation was responsible for the overexpression of LINC01503, and AR ligand-dependent cell growth, migration, and invasion in NPC cells. Taken together, our findings reveal that AR-induced LINC01503 can promote NPC progression through the SFPQ-FOSL1 axis, which represents a novel prognostic biomarker and therapeutic target for NPC patients.

Highlights

  • Nasopharyngeal carcinoma (NPC) is an epithelial malignant tumor that originates from the mucosa of the nasopharyngeal cavity [1]

  • Based on our previous long non-coding RNAs (lncRNAs) expression profile (GSE126683), we found that lncRNA LINC01503 was overexpressed in NPC tissues [3], but its biological function and regulatory mechanism involved in NPC have not been elucidated

  • LINC01503 is highly expressed in NPC and correlates with poor prognosis

Read more

Summary

Introduction

Nasopharyngeal carcinoma (NPC) is an epithelial malignant tumor that originates from the mucosa of the nasopharyngeal cavity [1]. NPC has a high incidence in Southeast Asia, especially in China, accounting for almost 40% of new cases worldwide [2]. Recent advances in intensity modulated radiation therapy and its combination with chemotherapy have remarkably improved the efficacy of NPC. These authors contributed : Shi-Wei He, Cheng Xu, YingQing Li

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call